Fibroblast growth factor-binding protein 1 (FGFBP1, FGF-BP) is a secreted chaperone that mobilizes paracrine-acting FGFs, stored in the extracellular matrix, and presents them to their cognate receptors. FGFBP1 enhances FGF signaling including angiogenesis during cancer progression, and is upregulated in various cancers. Here we evaluated the contribution of endogenous FGFBP1 to development and homeostasis as well as to skin pathologies utilizing Fgfbp1-knockout (KO) mice. Relative to wild-type (WT) littermates KO mice showed no gross pathologies. Still, in KO mice a significant thickening of the epidermis associated with a decreased transepidermal water loss and increased proinflammatory gene expression in the skin was detected. Also, skin carcinogen challenge by DMBA/TPA resulted in delayed and reduced papillomatosis in KO mice. This was paralleled by delayed healing of skin wounds and reduced angiogenic sprouting in subcutaneous matrigel plugs. Heterozygous GFP-knock-in mice revealed rapid induction of gene expression during papilloma induction and during wound healing. Examination of WT skin grafted onto Fgfbp1 GFP knockin reporter hosts and bone marrow transplants from the GFP reporter model into WT hosts revealed that circulating Fgfbp1-expressing cells migrate into healing wounds. We conclude that tissue-resident and circulating Fgfbp1-expressing cells modulate skin carcinogenesis and inflammation.
Introduction
The fibroblast growth factor binding protein (FGFBP) family consists of three human and two murine (FGFBP1, 3) members, which are secreted chaperone proteins that bind to FGFs and enhance their biological activity (Tassi and Wellstein 2006) . As the best characterized member, FGFBP1 has been shown to bind to FGF1, 2, 7, 10 and 22 in a reversible manner through its C-terminal domain (Tassi et al. 2011) . Paracrine FGFs (e. FGFBP1 is expressed in epithelial cells in skin, stomach, eye, ileum and colon (Aigner et al. 2002; Kurtz et al. 1997) , was found to act as an angiogenic switch molecule in cancer (Czubayko et al. 1997) and expressed in squamous cell carcinoma (Czubayko et al. 1994 ), pancreatic and colon cancer (Henke et al. 2006) . Also, FGFBP1 is upregulated during a two-step chemical skin carcinogenesis challenge with DMBA and TPA (Kurtz et al. 2004) . We have previously investigated the role of FGFBP1 in a transgenic mouse model and found that conditionally expressed FGFBP1 accelerated angiogenesis in subcutaneously implanted matrigel plugs, enhanced wound healing and reduced ischemic hindlimb injury. Furthermore, FGFBP1 and FGFBP2 play a critical role during chicken development: knockdown of either of them caused embryonic lethality in part through vascular leakage. (Gibby et al. 2009 ).
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To investigate the function of endogenous FGFBP1 we generated a knockout and a knock-in GFP-reporter mouse model, to investigate the role of FGFBP1 in development, skin homeostasis and repair and during challenge by chemical carcinogenesis.
Results

Generation of Fgfbp1-knockout mice
The complete Fgfbp1 open-reading-frame contained in exon 2 on chromosome 5 was replaced by a floxed Fgfbp1 gene and a neo-GFP cassette, resulting in Fgfbp1 +/loxP-neo-gfp mice, which were then crossed with mice expressing cre (Fig. 1a) . The resulting mouse line expressed GFP in lieu of Fgfbp1 (Fgfbp1 +/gfp ) and served to monitor activity of the Fgfbp1 promoter. To generate Fgfbp1-knockout mice (KO) the Fgfbp1 loxP-neo-gfp mice were crossed with mice expressing the recombinase Flpase and then with cre-expressing mice ( Fig. 1b-f ). The mouse strain in this study is primarily C57Bl/6N and to a lower degree SV129N.
The epidermis of KO mice is thicker and has a reduced permeability
Since endogenous FGFBP1 is predominantly expressed in skin (Aigner et al. 2002) , we initially focused on the analysis of the skin phenotype in the KO animals. The epidermis of adult (2-3 months old) but not juvenile KO mice (3 weeks old) showed a twofold increased thickness (p<0.05; Fig. 2a, S1a) . In contrast, the thickness of dermis, fat and panniculus muscle were not significantly different between WT and KO (Fig. 2b) . The increased thickness in KO mice coincided with an increased proliferation index in basal keratinocytes (Fig 2c, e) . Also, ~50% of the epidermis in KO mice showed multiple M A N U S C R I P T
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Commensurate with epidermal thickening in KO mice transepidermal water loss (TEWL) was decreased (Fig. 2f) . Also, global expression analysis of skin RNA, indicates significantly altered pathways related to barrier function in KO versus WT mice ( Fig.   S2a ) although staining for Claudin1 and Filaggrin showed no differences in the epidermis between WT and KO (Fig. 2e) . Analysis of RNA from the epidermis and from the dermis showed a higher expression of the macrophage marker F4/80 and Ffgr1c in the epidermis of KO mice (Fig. 2g) . In KO mice both Fgfr1b and c are expressed at similar levels in the dermis and epidermis, whilst a 10-fold higher expression of the c-isoform was seen in the dermis vs the epidermis of WT animals ( Fig. 2g ). Fgf7 and Fgfr2 were not differentially expressed in the epidermis or dermis (Fig. S1b) .
FGFBP1 upregulation in patients' psoriatic lesions and squamous cell skin cancer (SCC)
Epidermal thickening observed in the Fgfbp1-KO model has been described in inflammatory pathologies of the skin such as psoriasis (Stern 1997 ) and FGFR2 and FGF7 were found elevated in psoriatic skin (Guban et al. 2016) . To assess FGFBP1 gene expression we analyzed two previously published gene expression studies (Nair et al. 2009; Reischl et al. 2007 ) of paired samples of normal skin, psoriatic skin without and with lesions. FGFBP1 is significantly upregulated in lesions but not in unaffected skin (Fig. S3a, b) . Analysis of another study (Nindl et al. 2006 ) revealed that FGFBP1 is upregulated in actinic keratosis (AK) and invasive SCC relative to normal skin ( 
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Skin epidermis of KO mice shows elevated pro-inflammatory gene expression
A psoriatic phenotype can be mimicked in mice by topical application of Aldara, a proinflammatory agent (Walter et al. 2013 ) Fig. 3a) . Aldara contains Imiquimod and activates the innate immune system via TLR-7 on neutrophils, macrophages and dendritic cells and indirectly induces proliferation of keratinocytes (van der Fits et al. 2009 ). As a readout for activation by Aldara, we monitored Myeloperoxidase (MPO) activity, which increased during Aldara treatment in both WT and KO skin (Fig. 3b) . In response to Aldara, the expression of Fgfbp1 increased in WT mice (2.5-fold; Fig. 3c ) as did GFP activity in heterozygous GFP-reporter mice (Fgfbp1 +/gfp ; 6-fold; Fig. 3d , e). Aldara treatment also induced a striking, 4.5-fold epidermal thickening (Fig. 3f, g ) and expression of the inflammatory genes Il6 and Il17a as well as the epithelial marker Krt16 (Fig. 3h, S5a ). The expression of these genes was significantly elevated at baseline in the skin of KO mice, indicating a skin phenotype with activated immune response and thus increased epithelial proliferation (Fig. 2b, d, 3f, g ). It has been shown that the skin barrier function is highly dependent on FGF receptor expression (Yang et al. 2010) . Fgfr1,2, 3, 4 expression however, were not altered significantly in total skin (Fig. S4) . These data suggest that the loss of Fgfbp1 induces a baseline increase in pro-inflammatory gene expression in KO skin comparable to the Aldara treatment effect in WT.
DMBA/TPA-induced skin papilloma formation is reduced and delayed in KO mice
Fgfbp1 expression is increased in mouse skin during carcinogen-induced papilloma formation (Kurtz et al. 2004 ) suggesting a potential role during carcinogenesis. Six week
old GFP reporter mice (Fgfbp1 +/gfp ) treated topically with DMBA/TPA (Fig. 4a) showed macroscopically visible GFP activity in papillomas (Fig. 4b) , GFP protein expression in the more differentiated outer keratinocyte layers of the epidermis (Fig. 4c , magnified in Fig. S5b ) and >2-fold GFP mRNA (Fig. 4d) . In WT skin Fgfbp1 expression was induced similarly by 2.8-fold (Fig. 4k) . Skin biopsies taken from carcinogen treated WT and KO mice showed a similar increase in hyperplastic keratinocyte layers as early as 12 days after the first treatment and maximal thickness at 57 days (Fig. 4e) . However, the appearance of skin papillomas was significantly (p<0.01) delayed in KO mice: The first lesions in WT mice were found after 1.5 months (day 44) and only a month later (day 73) in the KO group (Fig. 4f, g ). By day 100 all WT mice developed papilloma whereas one KO mouse remained papilloma-free until the end of the experiment (Fig. 4g) . Also, the number of papilloma per mouse was significantly reduced in the KO mice (Fig. 4h) .
In addition to the reduced papilloma formation, we observed an increase of ulceration in the neck region of KO mice (Fig. S6a) . In earlier work, we had observed an impact of FGFBP proteins on vascular leakiness in embryonic tissues (Gibby et al. 2009 ) and it is known that altered vascular permeability can cause ulcerative inflammation (Nagy et al. 2008 ). Thus, we evaluated papilloma tissues for vessel integrity. Quite strikingly, the number of extravasated erythrocytes was increased >3-fold in the KO mice indicating a contribution of Fgfbp1 to vascular integrity in adult tissues (Fig. 4 i, j).
Pathway activation after DMBA/TPA challenges
To complement the phenotypic analyses, we compared the impact of DMBA/TPA treatment on the gene expression profile in skin and found robust gene expression M A N U S C R I P T
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10 difference associated with epidermal development, immune response and extracellular matrix (ECM) (Fig. S7) . Carcinogen treatment induced the activated keratinocytespecific genes Krt16 and Sprr2d to comparable levels in both WT and KO skin. Due to the elevated level at baseline, the relative induction by carcinogen was much lower in KO versus WT skin. The same pattern was observed for the immune response gene S100a8.
Its baseline level expression in untreated KO skin was 13-fold higher than the expression in WT skin and the induction by carcinogen treatment elevated its expression to similar levels in both KO and WT. Finally, the ECM protease Klk6 was upregulated at baseline by 4.3-fold in KO skin. DMBA/TPA treatment induced its expression in both WT and KO skin ( 
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Fgfbp1 expression is induced and required for timely wound healing
We have previously found that conditional transgenic FGFBP1 expression accelerates wound healing (Tassi et al. 2011 ). Complementary to that we observed a significant three-day delay in full-thickness skin wound healing in KO mice (Fig. 5a, b ). This supports a significant contribution of endogenous Fgfbp1 to timely wound healing.
Fgfbp1
+/gfp -reporter mice showed maximal levels of GFP fluorescence adjacent to the wounds on day 4 (Fig. 5c, d ). This was corroborated by IHC that showed a high expression of GFP protein close to the wounds and a low expression at remote skin ( (Fig. 5f , magnified in Fig. S8c) showed that the reëpithelialization of wounds in the WT mice was more advanced (Fig. 5g) . Also, the granulation tissue in wounds in KO mice contained a significantly higher number of extravasated erythrocytes and fewer microvessels and capillaries than WT mice (Fig. 5h,i magnified in Fig. S8c ) indicating less mature angiogenesis. There was a slight decrease in total cells in the granulation tissue of KO mice (Fig S8d) though no difference in their proliferation index (Fig. S8e, f) .
Fgfbp1-expressing cells are recruited to healing wounds
To investigate the expression of Fgfbp1 in cells recruited to healing wounds versus tissue resident cells we transplanted skin from WT donors onto the back of Fgfbp1 +/gfp recipient mice. The transplanted skin was wounded and the fluorescence of the wound and the surrounding transplant tissue was monitored (Fig. 6a) . The inside of wounds in wild type M A N U S C R I P T
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12 skin transplanted to Fgfbp1 +/gfp recipient mice started to fluoresce during wound healing even when surrounded by the non-fluorescent WT skin transplant (Fig. 6b, c) suggesting that GFP-expressing cells from the host entered the wound as early as two days after wounding. IHC analysis of the granulation tissue in the wound confirmed the influx of GFP-positive cells from the host (Fig. 6b) , thus corroborating that as late as five days after injury Fgfbp1-expressing cells localize to the wound.
In complementary experiments, Fgfbp1 +/gfp skin transplanted and wounded on a WT recipient showed increased GFP activity at edge of a wound as it healed but the GFP activity inside the open wound did not increase significantly ( Fig. S9a-d) . These results suggest the contribution of circulating cells from the host to the wound healing of the transplant and we thus tested that next in a separate experimental setting.
To test whether bone marrow can provide Fgfbp1-expressing (GFP positive) cells via the circulation to a healing wound, we isolated bone marrow cells from Fgfbp1 +/gfp mice and transplanted those into WT mice with skin wounds (Fig. 6d) . GFP fluorescence in the wounded area peaked at days two and three after wounding (Fig. 6e, f) and sections of the wounds showed strong GFP staining of cells in the granulation tissue (Fig. 6e, magnified in Fig. S9e) . These transplant experiments demonstrate that Fgbp1-expressing cells home to the wound from both the circulation and adjacent tissue and reveal that Fgfbp1-expressing bone marrow-derived cells are recruited to healing wounds.
Endogenous Fgfbp1 contributes to neoangiogenesis
Subcutaneous matrigel plugs are a well-defined model of neoangiogenesis that mimics part of the wound healing process and is driven by the invasion of monocytic cells
recruited from the circulation (Anghelina et al. 2004) . In earlier studies FGFBP1 was found expressed in tissue resident monocytes / macrophage (Ray et al. 2014 ) and gain-offunction studies had shown that expression of FGFBP1 enhances neoangiogenesis in a matrigel plug model (Tassi et al. 2011) . In Fgfbp1-KO mice, a significant 3-4-fold reduction of cells that fully invade the matrigel plug and reach the center was observed. It is noteworthy that similar numbers of infiltrating cells were observed at the edges of the plugs (regions 1 and 5; Fig. 6g, h) . Examination of matrigel plugs in Fgfbp1 +/gfp reporter mice revealed a strong GFP staining of the majority of invasive cells. A large percentage of the Fgfbp1-expressing cells were inflammatory cells with multilobular nuclei (Fig.   S9f ).
Additional phenotypic analysis of FGFBP1-KO mice
Fgfbp1-KO mice were viable and fertile and did not show any gross phenotypic abnormalities. The expected Mendelian ratio of the offspring indicated a lack of embryonic lethality in mice in contrast to chick embryonic development where FGFBP1
is crucial for survival (Gibby et al. 2009 ). To detect subtle phenotypic changes, we subjected a cohort of WT and KO animals to a systematic and comprehensive characterization for 550 parameters that include behavior, neurology, morphology, metabolism, hematology and immunology (Fuchs et al. 2009 ). In summary of the analyses detailed in Tables S1 to S21, and Figs. S10 to S15, we found significant phenotypic alteration in KO mice in the ratio of fat versus lean body mass, food intake, spleen and heart weights, blood glucose, cholesterol, iron binding capacity, lactate, urea, serum IgG3 and IgE, behavioral tests, and in the auditory brain stem response.
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Discussion
Previous studies have shown that FGFBP1 interacts with FGF1 and 2 as well as with members of the FGF7 subfamily i.e. FGF7, 10 and 22 (Beer et al. 2005) . These FGFs are expressed in the skin and signal through the IIIb isoform of FGFRs. Indeed, FGF22-knockout mice develop fewer papilloma than WT mice during skin carcinogenesis while skin development and wound healing is not affected (Jarosz et al. 2012 ). Mice lacking keratinocyte Fgfr1b and Fgfr2b lose epidermal barrier function and the ability to maintain skin homeostasis (Yang et al. 2010 ). Also, a lack of Fgfr2b in keratinocytes made skin hypersensitive to papilloma formation (Grose et al. 2007 ). We have previously found that DMBA/TPA upregulates FGFBP1 in human skin grafted onto mice (Kurtz et al. 2004) and the analysis of published data shown above revealed increased FGFBP1 expression in hyperproliferative skin diseases such as psoriasis, actinic keratosis and SCC.
Here we report that endogenous Fgfbp1 plays a significant role in skin repair and Kishibe et al. 2007; Lessard and Coulombe 2012; Prassas et al. 2015; Reichelt et al. 2004 ) and in chronic wounds (Singh et al. 2016) . Also, expression of the S100a8/a9 heterodimer which is thought to suppress papilloma formation (McNeill and Hogg 2014) is increased in the skin of KO mice (Fig. 4k) . Overall the loss of Fgfbp1 increases the pro-inflammatory gene expression in the skin.
The deletion of FGF22 led to a delay in carcinogen-induced papilloma formation (Jarosz et al. 2012 ) matching with our results. Wound healing was, however, not affected in In our study, during the inflammatory phase of wound healing (day 4) most of the inflammatory cells express Fgfbp1. Similarly, in the neoangiogenesis matrigel assay the majority of invasive, inflammatory cells express Fgfbp1. This corroborates previous results by us and others that FGFBP1 is expressed in tissue-infiltrating monocytes / macrophage (Ray et al. 2014 ).
In conclusion, our study identifies endogenous Fgfbp1 as a significant modulator of pathways that are involved in early carcinogenesis and inflammatory tissue regeneration M A N U S C R I P T
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and links Fgfbp1 expression to tissue-infiltrating inflammatory cells from the bone marrow.
Material and Methods
Mice
Mice were housed with food and water available ad libitum under standard laboratory conditions. For studies involving WT and KO mice, heterozygous breeder pairs were used and WT and KO littermates were selected for subsequent studies. Animals were separated based on sex, but not genotype. All animal studies were approved by Georgetown University's institutional animal care and use committee and conducted according to the NIH Guide for the Care and Use of Laboratory Animals.
Generation of knockout mice
The Fgfbp1-knockout targeting vector, Fgfbp1-KO mice and Fgfbp1 gfp mice in a C57BL/6 and SV129 mixed background were generated by Ingenious Targeting
Company and is described in the Supplemental Materials.
Transepidermal Water Loss (TEWL)
Mouse skin was analyzed in a non-invasive manner with a special Tewameter (AquaFlux-AF200) that was placed on the skin. During a short time of 60 to 90 seconds TEWL [g/(m 2 h)] was recorded (Fluhr et al. 2006) .
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
18
Illumina RNA expression assay and Ingenuity pathway analysis
PolyA-RNA was analyzed by the UCLA Neuroscience Genomics core utilizing an Illumina bead array (Mouse-ref8-v.2.0) system. RNA expression values were evaluated with the Ingenuity Pathway analysis software.
Separation of dermis from epidermis
The epidermis dissociation kit (Miltenyi-Biotec) was used for epidermis/dermis separation according to manufacturer's instructions.
Statistical Analyses
Prism5 (GraphPad) software was used to compare the means of two or more groups by Student's t-test or analysis of variance, respectively. Statistical significance was defined as P < 0.05. Figures legends: *, P<0.05; **, P<0.01; ***, P<0.001
An expanded Methods section is available in the Supplementary Materials and Methods.
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